Target type: biologicalprocess
Any process that stops or reduces the activity of an enzyme. [GOC:ebc, GOC:jl, GOC:tb, GOC:vw]
Negative regulation of catalytic activity is a fundamental biological process that controls the rate and extent of enzymatic reactions. It involves a complex interplay of molecules, including regulatory proteins, small molecules, and other cellular components, to modulate enzyme activity in response to various cellular cues. Here's a detailed description:
1. **Mechanism of Regulation:** The regulation of catalytic activity can occur through multiple mechanisms, including:
* **Allosteric Regulation:** Involves the binding of regulatory molecules to sites on the enzyme distinct from the active site, inducing conformational changes that alter enzyme activity. This can either enhance (activation) or inhibit (inhibition) the catalytic process.
* **Competitive Inhibition:** Involves the binding of an inhibitor molecule to the enzyme's active site, blocking the substrate from binding and preventing catalysis.
* **Noncompetitive Inhibition:** Involves the binding of an inhibitor to a site other than the active site, causing a conformational change that reduces the enzyme's catalytic efficiency.
* **Uncompetitive Inhibition:** Involves the binding of an inhibitor to the enzyme-substrate complex, preventing the formation of product.
* **Covalent Modification:** Involves the attachment or removal of chemical groups (e.g., phosphorylation, acetylation) to specific amino acid residues on the enzyme, altering its activity.
2. **Importance of Negative Regulation:** Negative regulation of catalytic activity is crucial for maintaining cellular homeostasis and responding to environmental changes. It allows cells to:
* **Control Metabolic Pathways:** By regulating enzyme activity, cells can control the rates of metabolic reactions, ensuring the efficient production and utilization of energy and essential molecules.
* **Respond to Environmental Stimuli:** Cells can adjust their enzymatic activity in response to external factors such as nutrient availability, stress, and signaling molecules, enabling them to adapt to changing conditions.
* **Prevent Excess or Uncontrolled Activity:** Negative regulation prevents the overproduction of certain molecules or the uncontrolled activation of enzymatic pathways that could be harmful to the cell.
3. **Examples of Negative Regulation:** Numerous examples illustrate negative regulation in biological systems:
* **Regulation of Glucose Metabolism:** The enzyme phosphofructokinase (PFK) is a key regulator of glycolysis. Its activity is negatively regulated by ATP, a product of glycolysis, ensuring that glucose is only broken down when energy is required.
* **Regulation of DNA Replication:** DNA polymerase is essential for DNA replication. Its activity is negatively regulated by the protein PCNA, ensuring that replication occurs only once per cell cycle.
* **Regulation of Transcription:** Transcription factors can bind to DNA to regulate gene expression. Their activity can be negatively regulated by other proteins or small molecules.
4. **Specificity and Complexity:** Negative regulation of catalytic activity is highly specific and often complex. Different enzymes are regulated by distinct mechanisms, and multiple factors can influence their activity. This complexity allows for fine-tuning of cellular processes and ensures that the appropriate responses are elicited in specific situations.
In conclusion, negative regulation of catalytic activity is an essential process that governs a wide range of cellular functions. By controlling enzyme activity, cells can maintain homeostasis, respond to environmental changes, and ensure the proper functioning of complex metabolic pathways.'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein mono-ADP-ribosyltransferase PARP9 | A protein mono-ADP-ribosyltransferase PARP9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8IXQ6] | Homo sapiens (human) |
Neurogenic locus notch homolog protein 1 | A neurogenic locus notch homolog protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P46531] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
calotropin | calotropin: structure in first source | cardenolide glycoside | |
rucaparib | AG14447: Poly(ADP-ribose) polymerase inhibitor; structure in first source | azepinoindole; caprolactams; organofluorine compound; secondary amino compound | antineoplastic agent; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |